Company intelligence / Profile preview

SCM AD Ventures

Luxembourg, Luxembourg

Ownership: Private
Development stage: Other

Overview

SCM AD Ventures appears to be a private Luxembourg-based venture capital and investment firm rather than an operating biotechnology, pharmaceutical, or healthcare company. Publicly available profiles describe it as an active investment firm founded in 2018 and headquartered in Luxembourg. The limited visible investment data suggests at least one disclosed life-science-related investment, including participation in Palliare's Series A financing, but there is no evidence that SCM AD Ventures itself develops therapeutic products or runs a drug pipeline. Based on the available information, it should be classified as an investor with some apparent exposure to healthcare rather than as a biotech operating company.

Industry: Investors

Beyond the preview

Go deeper on SCM AD Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCM AD Ventures.

Explore the full profile